RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 101–200 of 1,009
Hewitt, S. C., Deroo, B. J., Hansen, K., Collins, J., Grissom, S., Afshari, C. A., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0146 · Cited by 247
“Receptor (calcitonin) activity modifying protein 3 (RAMP3), a protein that is involved in transport of calcitonin like receptors to the plasma membrane, and in modification of receptors to determine their ligand specificity (47, 48), was robustly and rapidly induced (Table 3), and this induction was verified by RT-PCR…”
BackgroundCryo-EM structure of the active, Gs-protein complexed, human CGRP receptor
Liang, Y.-L., Khoshouei, M., Deganutti, G., Glukhova, A., Koole, C., Peat, T. S., Radjainia, M., Plitzko, J. M., Baumeister, W., Miller, L. J., et al. (2018) · Nature · doi:10.1038/s41586-018-0535-y · Cited by 238
Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic Application
Voors, A. A., Kremer, D., Geven, C., ter Maaten, J. M., Struck, J., Bergmann, A., Pickkers, P., Metra, M., Mebazaa, A., Düngen, H.-D., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1366 · Cited by 229
Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases
Carniglia, L., Ramírez, D., Durand, D., Saba, J., Turati, J., Caruso, C., Scimonelli, T. N., & Lasaga, M. (2017) · Mediators of Inflammation · doi:10.1155/2017/5048616 · Cited by 231
Hay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
Edvinsson, L. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12618 · Cited by 230
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1354 · Cited by 227
“angiogenesis, cell proliferation, and inflammation (12, 13) by acting through receptor complexes, which are either composed of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying protein 2 (RAMP2), or CRLR andRAMP3 (14, 15).”
BackgroundZhang, Z., Winborn, C. S., Marquez de Prado, B., & Russo, A. F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4542-06.2007 · Cited by 234
“RAMP1 is known to exist as monomer ( 15 kDa) and dimer ( 30 kDa), even under denaturing conditions (McLatchie et al., 1998). dependent activation of mitogen-activated protein (MAP) kinases (C. S. Winborn, unpublished data).”
BackgroundInfluentialAmylin Agonists: A Novel Approach in the Treatment of Diabetes
Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 239
“The hormone has a signal transduction pathway similar to calcitonin (CT), calcitonin gene–related peptide (CGRP), and adrenomedullin (3), and the specificity of the amylin receptor has been characterized.”
BackgroundLymph nodes are innervated by a unique population of sensory neurons with immunomodulatory potential
Huang, S., Ziegler, C. G. K., Austin, J., Mannoun, N., Vukovic, M., Ordovas-Montanes, J., Shalek, A. K., & von Andrian, U. H. (2021) · Cell · doi:10.1016/j.cell.2020.11.028 · Cited by 225
“Ramp1, which, together with Calcrl, a ubiquitously expressed gene among LN cell types, forms the CGRP receptor (McLatchie et al., 1998), wasmore highly expressed in innate immune cell types such asmast cells and DCs, suggesting that LNinnervating sensory neurons may signal to select myeloid cells via CGRP.”
BackgroundIUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
Harmar, A. J., Hills, R. A., Rosser, E. M., Jones, M., Buneman, O. P., Dunbar, D. R., Greenhill, S. D., Hale, V. A., Sharman, J. L., Bonner, T. I., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn728 · Cited by 227
Self-citationAdvances in G Protein-Coupled Receptor Allostery: From Function to Structure
Christopoulos, A. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094342 · Cited by 220
“create new receptor phenotypes or to bias signaling (McLatchie et al., 1998; Christopoulos et al., 1999, 2003; Hay et al., 2006).”
BackgroundJoost, P., & Methner, A. (2002) · Genome Biology · doi:10.1186/gb-2002-3-11-research0063 · Cited by 219
“Astonishingly, one family-B receptor, namely the CGRP receptor, requires coexpression with single transmembrane receptor activity-modifying proteins (RAMP1-3) for ligand binding and signal transduction [59].”
BackgroundCXCR7 impact on CXCL12 biology and disease
Sánchez-Martín, L., Sánchez-Mateos, P., & Cabañas, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.004 · Cited by 206
Nerves in Bone: Evolving Concepts in Pain and Anabolism
Brazill, J. M., Beeve, A. T., Craft, C. S., Ivanusic, J. J., & Scheller, E. L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3822 · Cited by 205
“CGRP signals through a G‐protein coupled receptor (GPCR) complex of calcitonin receptor‐like receptor (CALCRL) and receptor activity‐modifying protein 1 (RAMP1).((82)) In vitro, CGRP is osteoanabolic with potential for direct and indirect inhibition of catabolism.”
BackgroundRobert-Nicoud, M., Flahaut, M., Elalouf, J.-M., Nicod, M., Salinas, M., Bens, M., Doucet, A., Wincker, P., Artiguenave, F., Horisberger, J.-D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051603198 · Cited by 212
Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes
Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., & Sexton, P. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008615 · Cited by 210
“5 expressed, classical CGRP1-like pharmacology is observed (McLatchie et al., 1998; Hay et al., 2004).”
BackgroundRogers, M. E., Krieger, J., & Vogt, R. G. (2001) · Journal of Neurobiology · doi:10.1002/neu.1065 · Cited by 214
Villalón, C. M., & Olesen, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.003 · Cited by 209
Kee, Z., Kodji, X., & Brain, S. D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01249 · Cited by 196
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214218 · Cited by 209
“A reinterpretation of these data based on the elucidation of the CGRPα/ RAMP receptor system (53, 54) suggests that CGRP at high concentrations cross-reacts with the CT receptor.”
MethodMembrane Trafficking of G Protein–Coupled Receptors
Tan, C. M., Brady, A. E., Nickols, H. H., Wang, Q., & Limbird, L. E. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121558 · Cited by 211
The crosstalk between autonomic nervous system and blood vessels.
Sheng, Y., & Zhu, L. (2018) · PubMed · Cited by 281
The Role of Peptides in Central Sensitization
Seybold, V. S. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-79090-7_13 · Cited by 205
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 200
“The affinity of IAPP for the CTR-RAMP complex is higher, with an IC50 reported to be on the order of 8 nM for the CTR– RAMP-1 complex [25].”
InfluentialThe Identification of Ligands at Orphan G-Protein Coupled Receptors
Wise, A., Jupe, S. C., & Rees, S. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121419 · Cited by 201
Self-citationThe GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity
Ichikawa-Shindo, Y., Sakurai, T., Kamiyoshi, A., Kawate, H., Iinuma, N., Yoshizawa, T., Koyama, T., Fukuchi, J., Iimuro, S., Moriyama, N., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33022 · Cited by 201
Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets
Tang, X.-L., Wang, Y., Li, D.-L., Luo, J., & Liu, M.-Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.210 · Cited by 188
CGRP receptors in the control of pain and inflammation
Benemei, S., Nicoletti, P., Capone, J. G., & Geppetti, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.007 · Cited by 199
Linscheid, P., Seboek, D., Zulewski, H., Keller, U., & Müller, B. (2005) · Endocrinology · doi:10.1210/en.2004-1424 · Cited by 198
“CT-, CGRP-, ADM-, and amylin-mediated signaling occurs via calcitonin receptor (CTR) and CR-like receptor (CRLR) with receptor activity-modifying proteins (RAMPs) 1–3 determining specific binding (8).”
BackgroundRaddant, A. C., & Russo, A. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002067 · Cited by 192
G Protein–Coupled Receptor Deorphanizations
Civelli, O., Reinscheid, R. K., Zhang, Y., Wang, Z., Fredriksson, R., & Schiöth, H. B. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134548 · Cited by 193
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
Calcitonin and calcitonin receptors: bone and beyond
Pondel, M. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00176.x · Cited by 192
Wang, L., Shi, X., Zhao, R., Halloran, B. P., Clark, D. J., Jacobs, C. R., & Kingery, W. S. (2010) · Bone · doi:10.1016/j.bone.2009.11.029 · Cited by 198
“A functional CGRP receptor requires heterodimerization of CRL with a single-transmembrane domain protein, the receptor activity-modifying protein-1 (RAMP1), which allows the receptor complex to reach the cell surface [42,43].”
BackgroundG Protein-Coupled Receptors: A Century of Research and Discovery
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 176
“129 Originally thought to only interact with a limited number of family B receptors, recent studies have now demonstrated that RAMPs interact with a much wider range of GPCRs. 131,132 This likely is the tip of the iceberg, as other receptor-interacting proteins likely play additional roles in GPCR…”
Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions
Spier, A. D., & de Lecea, L. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00031-x · Cited by 197
The receptor concept: pharmacology's big idea
Rang, H. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706457 · Cited by 181
“They also associate with accessory proteins, such as RAMPs which alter their pharmacological properties (McLatchie et al., 1998; see also Brain & Cox, this issue).”
BackgroundReceptor activity modifying proteins
Sexton, P. M., Albiston, A., Morfis, M., & Tilakaratne, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00143-1 · Cited by 191
Neuropeptides and their receptors: innovative science providing novel therapeutic targets
Brain, S. D., & Cox, H. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706461 · Cited by 197
“The CGRP family of receptors are each composed of the same GPCR, calcitonin receptor-like receptor CL, which is involved in ligand binding, and which interacts in an essential manner with a single membrane spanning receptor activity modifying protein (RAMP; McLatchie et al., 1998).”
Backgroundter Haar, E., Koth, C. M., Abdul-Manan, N., Swenson, L., Coll, J. T., Lippke, J. A., Lepre, C. A., Garcia-Guzman, M., & Moore, J. M. (2010) · Structure · doi:10.1016/j.str.2010.05.014 · Cited by 189
“A subset of class BGPCRs, including CTR and CLR, formmultimeric complexes with receptor activity-modifying proteins, or RAMPs (McLatchie et al., 1998).”
BackgroundMallee, J. J., Salvatore, C. A., LeBourdelles, B., Oliver, K. R., Longmore, J., Koblan, K. S., & Kane, S. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109661200 · Cited by 190
The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling
Maudsley, S., Martin, B., & Luttrell, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083121 · Cited by 188
“…receptor flavors could preferentially interact with different ligands, e.g., CRLRRAMP1-recognizing calcitonin gene-related peptides and CRLR-RAMP2-RCP-binding adrenomedullin (McLatchie et al., 1998; Evans et al., 2000), or activate different downstream effectors in response to the same ligand.”
BackgroundCahill, C. M., Holdridge, S. V., & Morinville, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.003 · Cited by 184
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Recober, A., Kuburas, A., Zhang, Z., Wemmie, J. A., Anderson, M. G., & Russo, A. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1727-09.2009 · Cited by 186
“RAMP1 is a required subunit of the CGRP receptor that is necessary for trafficking to the cell surface and ligand-binding specificity (McLatchie et al., 1998).”
BackgroundVPAC Receptors for VIP and PACAP
Laburthe, M., Couvineau, A., & Marie, J.-C. (2002) · Receptors and Channels · doi:10.1080/10606820213680 · Cited by 188
G‐protein‐coupled receptors: past, present and future
Hill, S. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706455 · Cited by 182
“These were first discovered by Stephen Foord and his co-workers in the Receptor Systems and Cell Biology groups at GSK (Stevenage, U.K.), while investigating receptors for the calcitonin family of peptides (McLatchie et al., 1998).”
BackgroundAdrenomedullin: Potential in physiology and pathophysiology
Jougasaki, M., & Burnett, J. C. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00358-6 · Cited by 187
Petersen, K., Birk, S., Lassen, L., Kruuse, C., Jonassen, O., Lesko, L., & Olesen, J. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00830.x · Cited by 181
Ciruela, F., Escriche, M., Burgueño, J., Angulo, E., Casadó, V., Soloviev, M. M., Canela, E. I., Mallol, J., Chan, W.-Y., Lluis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006960200 · Cited by 180
Identification of neuromedin S and its possible role in the mammalian circadian oscillator system
Mori, K., Miyazato, M., Ida, T., Murakami, N., Serino, R., Ueta, Y., Kojima, M., & Kangawa, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600526 · Cited by 183
“The functional activity of receptors in the CNS may be modulated by unknown modifying molecules, such as receptor-activity-modifying proteins (McLatchie et al, 1998).”
BackgroundIslet amyloid: From fundamental biophysics to mechanisms of cytotoxicity
Cao, P., Marek, P., Noor, H., Patsalo, V., Tu, L.-H., Wang, H., Abedini, A., & Raleigh, D. P. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.046 · Cited by 179
“IAPP receptors are generated from co-expression of the CT receptor with one of three RAMPs [25].”
BackgroundThe role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182
“[33], who screened an expression cDNA library from the human neuroblastoma cell line SK-N-MC in Xenopus oocytes, aiming to clone a specific CGRP receptor.”
BackgroundSun, R.-Q., Tu, Y.-J., Lawand, N. B., Yan, J.-Y., Lin, Q., & Willis, W. D. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00339.2004 · Cited by 180
Wingless transduction by the Frizzled and Frizzled2 proteins of Drosophila
Chen, C.-M., & Struhl, G. (1999) · Development · doi:10.1242/dev.126.23.5441 · Cited by 188
The role of amylin in the control of energy homeostasis
Lutz, T. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00703.2009 · Cited by 175
“Further, amylin-induced c-Fos mRNA and RAMP3 mRNA expression colocalize in the rat AP (7), and amylin-sensitive AP neurons carry the CT-R (8).”
BackgroundInfluentialVenner, J. M., Hidalgo, L. G., Famulski, K. S., Chang, J., & Halloran, P. F. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13115 · Cited by 166
“RAMP3 transports CALCRL to the plasma to produce a dual receptor for the potent vasodilators calcitonin gene related peptide and adrenomedullin (46).”
BackgroundCalcitonin gene-related peptide and its role in migraine pathophysiology
Arulmani, U., MaassenVanDenBrink, A., Villalón, C. M., & Saxena, P. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.035 · Cited by 176
“Though CGRP and adrenomedullin bind with calcitonin receptor-like receptor, the receptor specificity is being determined by a single transmembrane domain protein, termed as the receptor activity modifying protein (RAMP) (McLatchie et al., 1998).”
InfluentialCurrent understanding of trigeminal ganglion structure and function in headache
Messlinger, K., & Russo, A. F. (2019) · Cephalalgia · doi:10.1177/0333102418786261 · Cited by 178
“RAMP proteins are necessary for the trafficking of CLR to the cell membrane, and specific RAMPs define the ligand specificity of the calcitonin receptor family (45).”
BackgroundRomero, G., von Zastrow, M., & Friedman, P. A. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385952-5.00003-8 · Cited by 172
“CRLR dimerized with RAMP3, for instance, forms a high-affinity receptor for adrenomedullin (McLatchie et al., 1998).”
Petersen, K. A., Lassen, L. H., Birk, S., Lesko, L., & Olesen, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.001 · Cited by 173
“48 These results, together with the findings that SK-N-MC cell lines only express the CGRP 1 receptor”
ResultFernandez-Patron, C., Stewart, K. G., Zhang, Y., Koivunen, E., Radomski, M. W., & Davidge, S. T. (2000) · Circulation Research · doi:10.1161/01.res.87.8.670 · Cited by 175
Nishimatsu, H., Suzuki, E., Nagata, D., Moriyama, N., Satonaka, H., Walsh, K., Sata, M., Kangawa, K., Matsuo, H., Goto, A., et al. (2001) · Circulation Research · doi:10.1161/hh1301.092498 · Cited by 175
Decreased Bone Formation and Osteopenia in Mice Lacking α-Calcitonin Gene-Related Peptide
Schinke, T., Liese, S., Priemel, M., Haberland, M., Schilling, A. F., Catala-Lehnen, P., Blicharski, D., Rueger, J. M., Gagel, R. F., Emeson, R. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040915 · Cited by 177
Wu, M., Linderoth, B., & Foreman, R. D. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2007.11.001 · Cited by 174
“ADM also can produce vasodilation by binding CGRP-1 receptor, although its vasodilation effect is relatively weaker when compared to CGRP (Aiyar et al., 1996; McLatchie et al., 1998; Hagner et al., 2002).”
BackgroundNeurogenic mechanisms in bronchial inflammatory diseases
Groneberg, D. A., Quarcoo, D., Frossard, N., & Fischer, A. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00665.x · Cited by 178
“Interestingly, the activity of CGRP receptors is regulated by a family of receptor activity-modifying proteins (RAMP) leading to different type I or type II CGRP receptors (72).”
BackgroundKaupmann, K., Schuler, V., Mosbacher, J., Bischoff, S., Bittiger, H., Heid, J., Froestl, W., Leonhard, S., Pfaff, T., Karschin, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14991 · Cited by 173
Wilson, M. C., Meredith, D., & Halestrap, A. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109658200 · Cited by 172
The molecular pharmacology of CGRP and related peptide receptor subtypes
Juaneda, C., Dumont, Y., & Quirion, R. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01555-8 · Cited by 173
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
Cornish, J., Callon, K. E., Bava, U., Kamona, S. A., Cooper, G. J. S., & Reid, I. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00494-x · Cited by 173
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Tso, A. R., & Goadsby, P. J. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0463-4 · Cited by 161
Dieterich, L. C., Tacconi, C., Ducoli, L., & Detmar, M. J. (2022) · Physiological Reviews · doi:10.1152/physrev.00039.2021 · Cited by 179
Bouschet, T., Martin, S., & Henley, J. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02598 · Cited by 169
“Jo ur na l o f C el l S ci en ce 4710 amino acid sequence identity (McLatchie et al., 1998; Morfis et al., 2003).”
BackgroundMethodResultInfluentialFraser, N. J., Wise, A., Brown, J., McLatchie, L. M., Main, M. J., & Foord, S. M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23257-0 · Cited by 169
“We have previously reported that RAMPs 2 and 3 interact with CRLR to produce an ADM receptor when coexpressed in Xenopus oocytes (McLatchie et al., 1998).”
InfluentialSelf-citationRoggenkamp, D., Köpnick, S., Stäb, F., Wenck, H., Schmelz, M., & Neufang, G. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.464 · Cited by 161
Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
De Logu, F., Nassini, R., Hegron, A., Landini, L., Jensen, D. D., Latorre, R., Ding, J., Marini, M., Souza Monteiro de Araujo, D., Ramírez-Garcia, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28204-z · Cited by 158
Zudaire, E., Martı́nez, A., & Cuttitta, F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00037-5 · Cited by 162
Procalcitonin: How a hormone became a marker and mediator of sepsis
Becker, K. (2001) · Swiss Medical Weekly · doi:10.4414/smw.2001.09751 · Cited by 170
Lu, M., Echeverri, F., & Moyer, B. D. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00097.x · Cited by 169
Glycosaminoglycan modification of neuropilin‐1 modulates VEGFR2 signaling
Shintani, Y., Takashima, S., Asano, Y., Kato, H., Liao, Y., Yamazaki, S., Tsukamoto, O., Seguchi, O., Yamamoto, H., Fukushima, T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601188 · Cited by 167
“Recent reports suggest that stable cell-surface receptor expression in the absence of ligand sometimes requires a specific adaptor protein or co-receptor (McLatchie et al, 1998; Loconto et al, 2003; Saito et al, 2004).”
BackgroundDuvernay, M. T., Zhou, F., & Wu, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313881200 · Cited by 162
Regulation of signal transduction by calcitonin gene-related peptide receptors
Walker, C. S., Conner, A. C., Poyner, D. R., & Hay, D. L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.006 · Cited by 166
Tilakaratne, N., Christopoulos, G., Zumpe, E. T., Foord, S. M., & Sexton, P. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39040-8 · Cited by 165
“The mechanism by which RAMPs convert a particular receptor to another is not well understood, although they have been shown to be involved in the regulation of terminal glycosylation and trafficking of CRLR to the cell surface (McLatchie et al., 1998; Fraser et al., 1999).”
Self-citationAdrenomedullin: A Protective Factor for Blood Vessels
Kato, J., Tsuruda, T., Kita, T., Kitamura, K., & Eto, T. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000184759.91369.f8 · Cited by 164
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
Tal, R., & Segars, J. H. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt042 · Cited by 159
“CLR association with RAMP2 or RAMP3 promotes adrenomedullin binding, whereas heterodimerization with RAMP1 promotes CGRP binding (McLatchie et al., 1998).”
BackgroundKuwasako, K., Shimekake, Y., Masuda, M., Nakahara, K., Yoshida, T., Kitaura, M., Kitamura, K., Eto, T., & Sakata, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004534200 · Cited by 160
Eftekhari, S., & Edvinsson, L. I. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-112 · Cited by 160
“The receptor for CGRP consists of a complex of a seven transmembrane-spanning protein, calcitonin receptor-like receptor (CLR), a single transmembranespanning protein designated receptor activity modifying protein 1 (RAMP1) [8] and an intracellular protein, receptor component protein (RCP) [9].”
BackgroundGolpon, H. A., Puechner, A., Welte, T., Wichert, P. V., & Feddersen, C. O. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00300-7 · Cited by 158
Buhlmann, N. (1999) · Endocrinology · doi:10.1210/en.140.6.2883 · Cited by 156
Kim, F. J., Kovalyshyn, I., Burgman, M., Neilan, C., Chien, C., & Pasternak, G. W. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.057083 · Cited by 165
“Opioid receptors are heterotrimeric G-protein-coupled receptors (GPCRs) whose functionality is determined by macromolecular receptor assemblies comprising receptors and G-proteins as well as associated cellular factors such as regulators of G-protein signaling, various receptor activity-modifying proteins, and G-prote…”
BackgroundHomer-Dependent Cell Surface Expression of Metabotropic Glutamate Receptor Type 5 in Neurons
Ango, F., Robbe, D., Tu, J. C., Xiao, B., Worley, P. F., Pin, J., Bockaert, J., & Fagni, L. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1100 · Cited by 167
The regulatory mechanisms of export trafficking of G protein-coupled receptors
Duvernay, M. T., Filipeanu, C. M., & Wu, G. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.020 · Cited by 177
Immunotherapy in sepsis - brake or accelerate?
Steinhagen, F., Schmidt, S. V., Schewe, J., Peukert, K., Klinman, D. M., & Bode, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107476 · Cited by 164
Mikami, N., Matsushita, H., Kato, T., Kawasaki, R., Sawazaki, T., Kishimoto, T., Ogitani, Y., Watanabe, K., Miyagi, Y., Sueda, K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100028 · Cited by 151
“The primers used were RAMP1 forward, 59-GGGCTCTGCTTGCCATGG-39; RAMP1 reverse, 59-CACCTGGGATACCTACAC-39; CLR forward, 59-GGACGGATGGCTATGC-39; CLR reverse, 59-CAGGTAAACGCCTTCAC-39; Langerin forward, 59-CCAAGGACTACAGAACAGCTT39; Langerin reverse, 59-ACAGAAAGACCACAGGCT-39; CCR2 forward, 59-AGGCCATGCAGGTGACAG-39; CCR2 rever…”
InfluentialAdrenomedullin--what do we know 10 years since its discovery?
Bełtowski, J., & Jamroz, A. (2004) · PubMed · Cited by 180
Neurovascular mechanisms of migraine and cluster headache
Hoffmann, J., Baca, S. M., & Akerman, S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17733655 · Cited by 163
Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics
Tao, Y., & Conn, P. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1121 · Cited by 156
Facilitation of Synaptic Transmission and Pain Responses by CGRP in the Amygdala of Normal Rats
Han, J. S., Adwanikar, H., Li, Z., Ji, G., & Neugebauer, V. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-10 · Cited by 161
“Functional CGRP1 receptors are formed by a heterodimeric complex of the calcitonin receptor-like receptor (CRLR) and receptor activitymodifying protein 1 (RAMP1) [69,70].”
BackgroundInfluentialThe TRPA1 channel in migraine mechanism and treatment
Benemei, S., Fusi, C., Trevisan, G., & Geppetti, P. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12512 · Cited by 162
“…receptor-like receptor (CLR; Aiyar et al., 1996), a single transmembrane spanning protein called receptor activity-modifying protein 1 (RAMP1; McLatchie et al., 1998), required for the binding of CGRP to CLR and the receptor component protein (Ma et al., 2003) that characterizes the…”
Background
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.